Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
29.26
-1.71 (-5.52%)
At close: Apr 4, 2025, 4:00 PM
28.89
-0.37 (-1.27%)
After-hours: Apr 4, 2025, 6:56 PM EDT
HRMY Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for HRMY stock have an average target of 54, with a low estimate of 40 and a high estimate of 70. The average target predicts an increase of 84.55% from the current stock price of 29.26.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HRMY stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $42 → $44 | Buy | Maintains | $42 → $44 | +50.38% | Mar 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $75 → $70 | Strong Buy | Maintains | $75 → $70 | +139.23% | Feb 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +70.88% | Feb 26, 2025 |
| Needham | Needham | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +70.88% | Feb 25, 2025 |
| Mizuho | Mizuho | Buy Maintains $52 → $42 | Buy | Maintains | $52 → $42 | +43.54% | Feb 20, 2025 |
Financial Forecast
Revenue This Year
858.12M
from 714.73M
Increased by 20.06%
Revenue Next Year
1.02B
from 858.12M
Increased by 18.40%
EPS This Year
3.14
from 2.51
Increased by 25.16%
EPS Next Year
4.28
from 3.14
Increased by 36.36%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 902.6M | 1.1B | 1.4B | ||
| Avg | 858.1M | 1.0B | 1.2B | ||
| Low | 803.5M | 915.1M | 1.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.3% | 28.3% | 38.1% | ||
| Avg | 20.1% | 18.4% | 20.6% | ||
| Low | 12.4% | 6.6% | -0.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.22 | 5.25 | 7.88 | ||
| Avg | 3.14 | 4.28 | 5.72 | ||
| Low | 1.62 | 2.77 | 4.44 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 68.2% | 67.1% | 83.8% | ||
| Avg | 25.2% | 36.4% | 33.6% | ||
| Low | -35.6% | -11.7% | 3.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.